Christian Hengstenberg
Latest contributions
Identification and treatment of (sub)clinical transcatheter valve thrombosis
16 May 2024 – From EuroPCR 2024
This session offers a practical guide to CT diagnosis of HALT/RLM, highlighting the importance of taking HALT/RLM seriously and providing insights into approaching HALT/HAM and the potential impact of pharmacotherapy. Gain knowledge on determining leaflet thickening and mobility through MSCT, receive updates on antithrombotic treatment strategies...
New data on TAVI
16 May 2024 – From EuroPCR 2024
This session presents the latest research and data on transcatheter aortic valve implantation (TAVI). It covers a range of topics, including long-term results of TAVI versus surgical aortic valve replacement in low-risk severe aortic stenosis, real-world experience with novel transcatheter heart valve devices, outcomes in patients...
Trial updates and featured clinical research
16 May 2024 – From EuroPCR 2024
This session showcases a selection of the latest clinical research and trial updates presented at EuroPCR 2024. Attendees will have the opportunity to learn about the findings from studies evaluating the use of OCT-guided PCI for chronic total occlusions, the safety and efficacy of short dual...
Align for the future with case-based discussions on next generation balloon expandable transcatheter heart valve technology
16 May 2024 – From EuroPCR 2024
Join this EuroPCR 2024 session to delve into the cutting-edge innovations and techniques shaping transcatheter heart valve interventions. Witness firsthand the versatility of the Myval Octacor THV platform, navigating through challenging scenarios with ease, explore the significance of lifetime patient management in TAVI, unveiling the novel...
Valve-in-valve: the journey starts with the first prosthesis
17 May 2022 – From EuroPCR 2022
In this EuroPCR 2022 session featuring Philip Maccarthy, Julia Mascherbauer, Hendrik Treede, Christian Hengstenberg, Radoslaw Parma, and Giuseppe Tarantini, analyze the impact of valve-in-valve interventions on lifetime management, learn about particular clinical considerations and the procedural technique of TAVI-in-TAVI procedures, and appreciate the potential pitfalls of...
Improving efficiency in TAVI by implementing an early discharge program
Watch this session with Christian Hengstenberg, Mika Laine & Stefan Toggweiler to learn more which variable need to be take into account for improving efficiency in TAVI by implementing an early discharge program.
This interview supported by Boston Scientific was filmed at PCR Valves e-Course 2020 : see more...
The year in intervention: essential publications from the EuroIntervention Journal and the European Heart Journal
23 May 2019 – From EuroPCR 2019
Consult this session to discover the essential papers from the EuroIntervention Journal and the European Heart Journal in 2019, regarding hypertension, coronary interventions, and more!
Valve-in-valve: not that simple after all!
21 May 2019 – From EuroPCR 2019
Consult this session to discover complex TAVI clinical cases, and find out about innovative treatment options, how to assess the risks of this procedure and how to tackle potential complications.
TAVI: imaging and topics
17 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to learn more about various TAVI topics, such as the clinical impact of HALT after TAVI in early phases, the prognostic impact of deterioration in nutrition status after TAVI, aortic valvular calcification patterns on CT as predictor for permanent pacemaker implantation after TAVR,...
Hot topics in the pharmacologic treatment after TAVI – Current concepts
16 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to learn more about the risk of valve thrombosis, thrombo-embolic and bleeding events after TAVI and the rationale of antithrombotic treatment regimens in atrial fibrillation patients post TAVI.
